Replies to post #1544 on Momenta Pharmaceuticals, Inc. (MNTA)

[HattieTheWitch]

From go seek:

Rumor: Market talk that TEVA is interested in Momenta Pharma (MNTA) for $21 per share. (RANsquawk)

seekingalpha.com/article/251519-deal-watch-after-huffpo-are-gawker-and-business-insider-next-media-targets?source=yahoo

FWIW

From Dew:

LOL

Actually, I could see TEVA exploring such a thing. While the FTC would no doubt disallow TEVA from "cornering the market" on generic versions of enox (and Copaxone?), could you imagine the value of MNTA's technology to a company like TEVA? TEVA nakes great money off of its generics, right? What would absorbing MNTA do except accelerate its ability to do so?

Certainly there would be obstacles to such an acquisition, but TEVA would be in a far stronger position as a manufacturer of generics, wouldn't they?

Am I all wet? If so, please enlighten me.